Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

Vertex appreciates the strong support that its ... entered into in connection with the Plan will be provided in a Form 8-K, which can be viewed on the Company's website or the Securities and ...

Google has released several new Gemini models, including 2.0 Flash-Lite for cost efficiency, 2.0 Flash Thinking Experimental ...

Highlights,Increased institutional ownership in Vertex Inc. with notable transactions recorded.,Strong year-over-year revenue ...

Sera Prognostics, Inc., The Pregnancy Company® ("Sera" or the "Company") , which focuses on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors ...

Government, IoT, and Cybersecurity sectors, announced today that it has entered into securities purchase agreements with certain institutional investors to purchase 545,454 ordinary ...

Q4 2024 Earnings Call Transcript February 4, 2025 Alphabet Inc. beats earnings expectations. Reported EPS is $2.15, ...

Two elements A[i] and A[j] form an inversion if A[i] > A[j] but i ... Given an undirected graph represented as an adjacency matrix and an integer k, write a function to determine whether each vertex ...

Vertex (VRTX) stock was trading largely flat post-market after the company released its Q4 earnings report and issued 2025 ...

Vertex Pharmaceuticals Inc. will soon lose a member of its leadership team that helped the company achieve major revenue ...

Vertex Pharmaceuticals ( VRTX) reported fourth-quarter revenue and offered an outlook for 2025 that topped analysts’ expectations. The company said it anticipates 2025 revenue of $11.75 billion to $12 ...